[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368947-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368947-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","5-hydroxymethylcytosine-analysis-reveals-stable-epigenomic-changes-in-tumor-tissue-that-enable-cancer-detection-in-cell-free-dna","5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNA","","5-hydroxymethylcytosine (5hmC) is a stable epigenomic mark linked to gene regulation and tumorigenesis. Epigenomic distribution of 5hmC was profiled in tumor tissues (n=217), normal tissues (n=50), and cell-free DNA (cfDNA) from cancer (n=1009) and non-cancer subjects (n=1678) across breast, colon, lung, ovarian, and pancreatic cancers. The work identifies cancer-specific 5hmC redistributions persisting from early to late stage, defines tissue-specific differential hydroxymethylation regions, and trains a model using these regions to predict tissue of tumor origin with 85.2% accuracy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/5-hydroxymethylcytosine-analysis-reveals-stable-epigenomic-changes-in-tumor-tissue-that-enable-cancer-detection-in-cell-free-dna/368947/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/5-hydroxymethylcytosine-analysis-reveals-stable-epigenomic-changes-in-tumor-tissue-that-enable-cancer-detection-in-cell-free-dna/368947.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study measure to evaluate cancer detection potential?","Question",{"text":63,"@type":64},"It measures 5-hydroxymethylcytosine (5hmC) epigenomic distribution in tumor tissues, normal tissues, and cell-free DNA (cfDNA).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How are tissue-specific signals used to improve prediction from cfDNA?",{"text":68,"@type":64},"The study identifies differential hydroxymethylation regions (DhmRs) that are tumor tissue specific, then trains models using tissue-derived 5hmC features to predict tissue of tumor origin in cfDNA.",{"name":70,"@type":61,"acceptedAnswer":71},"What predictive performance is reported for tissue-of-origin classification?",{"text":72,"@type":64},"A multinomial logistic regression model trained on tissue-specific DhmRs predicts tissue of tumor origin (TOTO) in cfDNA with 85.2% accuracy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368947,1790332368,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","communications biology Article  \nA Nature Portfolio journal  \n[https://doi.org/10.1038/s42003-025-09017-4](https://doi.org/10.1038/s42003-025-09017-4)  \n5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissuethat enable cancer detection in cellfree DNA  \n Check for updates  \n\n| Yuan Xue1,3, Yuhong Ning1,3, Verena Friedl1, David Haan2, Anna Bergamaschi2, Gulfem D. Guler1, Kyle Hazen1, Aaron Scott1, Tierney Phillips2, Erin McCarthy2, Christopher K. Ellison2, Roger Malta2, Albert Nguyen2, Vanessa Lopez2, Romola Cavet2, Melissa Peters2, Judith Sheard2, William Gibb1, Shimul Chowdhury2, Wayne Volkmuth1 & Samuel Levy 2  |  |\n| --- | --- |\n| 5-hydroxymethylcytosine (5hmC) is a stable epigenomic mark associated with gene regulation and tumorigenesis. To evaluate its potential for multi-cancer detection, epigenomic distribution of 5hmC was analyzed in tumor tissues(n = 217), normal tissues (n = 50), and cell-free DNA(cfDNA) from cancer (n = 1009) and non-cancer subjects (n = 1678) across breast, colon, lung, ovarian, and pancreatic cancers. Differential analysis revealed extensive redistribution of 5hmC in early-stage tumors that persisted into the late-stage, while global 5hmC abundance decreased in all tumors. Two distinct patterns of hydroxymethylation distribution were identiﬁed: one common across cancers and another tissue speciﬁc. Differential hydroxymethylation regions (DhmRs) that were tumor tissue speciﬁc had signiﬁcantly improved cancer prediction incfDNA. A multinomial logistic regression model was trained on tissue-speciﬁc DhmRs to predict Tissue of Tumor Origin (TOTO) of cfDNA with 85.2% accuracy. These ﬁndings demonstrate that stable, cancer-speciﬁc 5hmC signatures appear to be established early in tumorigenesis persist throughout disease progression, suggesting 5hmC as a potential pancancer marker for early and late-stage tumor detection via liquid biopsy. |  |\n| DNA 5-methylcytosine (5mC) and its oxidized form, DNA 5-hydroxymethylcytosine (5hmC) are prevalent epigenetic markers that play crucial roles in regulating gene expression within the human genome1. 5mC is commonly associated with regions that are transcriptionally inactive, while5hmC levels in gene bodies and enhancers are strongly correlated with transcriptional activity2–4. Recent technical advances have enabled the characterization of 5mC and 5hmC distribution in the human genome across different tissue origins2,5,6. Analysis of 5mC patterns has identiﬁed methylation signatures in cell free DNA (cfDNA) that correlate with a number of cancers at various stages, inspiring the development of a multicancer screening test7–9. Various biotechnology applications have demonstrated promising result in predicting the tissue of tumor origin (TOTO) based on methylation signatures incfDNA analyte10;however, no study as of date has investigated the correlation of 5hmC signals in tumor tissues and cancer cfDNA on a genomic scale. | Ongoing studies have continued to contribute to our understanding of 5hmC modiﬁcations in regulating transcriptional dynamics during cellular, developmental, and pathological processes2, 11. In particular, tissue-speciﬁc genomic variation of 5hmC levels have been observed in the course of normal tissue development as well as during tumorigenesis12. It is thought that bloodborne cfDNA are partially digested DNA fragments that originate from tissues and circulatory blood cells, creating a mixture of DNA with epigenomic patterns that can reﬂect their cellular origins. This complex mixture has been shown to be a dynamic representation of tissue health within the body, enabling routine screening tests due to its availability and ease of access13, 14. By isolating 5hmC-modiﬁed cfDNA fragments from blood plasma, several studies have identiﬁed 5hmC patterns that are associated with distinct cancer types and demonstrated the feasibility in constructing a predictive model for classifying cancer patients15–18. However, it remains ","cbCais6fJt5XNOCG","https://ap.wps.com/l/cbCais6fJt5XNOCG","pdf",3289176,15,"English","# Methods\n## Clinical cohorts and study design of tumor tissues\n## Epigenomic analysis and differential hydroxymethylation regions\n## Two-step prediction model for cancer status and tissue of tumor origin","[{\"question\":\"What does the study measure to evaluate cancer detection potential?\",\"answer\":\"It measures 5-hydroxymethylcytosine (5hmC) epigenomic distribution in tumor tissues, normal tissues, and cell-free DNA (cfDNA).\"},{\"question\":\"How are tissue-specific signals used to improve prediction from cfDNA?\",\"answer\":\"The study identifies differential hydroxymethylation regions (DhmRs) that are tumor tissue specific, then trains models using tissue-derived 5hmC features to predict tissue of tumor origin in cfDNA.\"},{\"question\":\"What predictive performance is reported for tissue-of-origin classification?\",\"answer\":\"A multinomial logistic regression model trained on tissue-specific DhmRs predicts tissue of tumor origin (TOTO) in cfDNA with 85.2% accuracy.\"}]","5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNA | PDF",1790179692,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47fd79a6591eb9fad7ceb1c6d9ea10c4.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fda5115ef5af8fd8b261580e3fe4116.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7cc92ce4dacab9ce09270f476aa52ef.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e01dee49f8d45545e5bca85a9c47b90.webp",980,1301]